Finally, after more than 3 months working remotely, we are back at the office! Of course, keeping all the safety […]

During the past months, at Viromii we have been working with some innovative cancer therapies. Concretely, we have been working […]

An entire year has passed, and from Viromii we can say that it has been really exciting and we have […]

Recently, at Viromii we have been working with a new type of sensor for glucose monitoring. Specifically, we are performing […]

In one of the most privileged environments of the city of Valencia, also qualified as the pole of innovation and […]

As all of you know, we develop services for supporting technology transfer operations in research-based institutions such as universities and […]

More or less one year ago, we came back to Spain from Sweden with the idea of setting up a […]

Recently, at Viromii, we have been working on a really interesting project regarding phage therapy, a promising area that can help […]

In the previous post, we explored the different preventive strategies pharma companies use to maintain their market exclusivity. At Viromii we feel this […]

For some time at Viromii we have been developing a tool that facilitates technology transfer activities by helping experts identify […]

In the previous post we could see the greatly negative impact that losing market exclusivity has over the financials of pharmaceutical companies, […]

Lately, at Viromii, we have been working with some really interesting projects in the pharma industry, this has made us […]

In the previous post, we explained the impact of the teacher’s exemption over university’s technology transfer performance. However, in this […]

Universities are the cradle of knowledge, new technologies and innovation. These new technologies and innovations can be the base for […]

We, at Viromii. have asked this question to many actors within the european startup ecosystem, and found interesting insights that […]